Press Releases

Home > Press Releases

Press Releases (Page 196)

SHOALS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Shoals Technologies Group, Inc. and Encourages Investors to Contact the Firm

NEW YORK, March 24, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (NASDAQ: SHLS) in the United States District Court for the Middle District of Tennessee on behalf of all persons and entities who purchased or otherwise acquired Shoals common stock between... ❯❯❯

AGILON ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against agilon health, inc. and Encourages Investors to Contact the Firm

NEW YORK, March 24, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL) in the United States District Court for the Western District of Texas on behalf of all persons and entities who purchased or otherwise acquired agilon securities between Agilon... ❯❯❯

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Children’s Place, and Ventyx and Encourages Investors to Contact the Firm

NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of The Children’s Place (NASDAQ: PLCE), and Ventyx Biosciences, Inc. (NASDAQ: VTYX). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be... ❯❯❯

LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating Lifecore Biomedical, Inc. on Behalf of Lifecore Stockholders and Encourages Investors to Contact the Firm

NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) (NASDAQ: LFCR) on behalf of Lifecore stockholders. Our investigation concerns whether Lifecore has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to... ❯❯❯

ARMOUR ALERT: Bragar Eagel & Squire, P.C. is Investigating ARMOUR Residential REIT, Inc. on Behalf of ARMOUR Stockholders and Encourages Investors to Contact the Firm

NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against ARMOUR Residential REIT, Inc. (“ARMOUR” or the “Company”) (NYSE: ARR) on behalf of ARMOUR stockholders. Our investigation concerns whether ARMOUR has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate... ❯❯❯

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hut 8, Anavex, and Innoviz and Encourages Investors to Contact the Firm

NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Hut 8 Corp. (NASDAQ: HUT), Anavex Life Sciences Corp. (NASDAQ: AVXL), and Innoviz Technologies Ltd. (NASDAQ: INVZ;INVZW). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.... ❯❯❯

APPLE ALERT: Bragar Eagel & Squire, P.C. is Investigating Apple Inc. on Behalf of Apple Stockholders and Encourages Investors to Contact the Firm

NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Apple Inc. (“Apple” or the “Company”) (NASDAQ: AAPL) on behalf of Apple stockholders. Our investigation concerns whether Apple has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. ... ❯❯❯

ADM DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Archer-Daniels-Midland Company and Encourages Investors to Contact the Firm

NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Archer-Daniels-Midland Company (“ADM” or the “Company”) (NYSE: ADM) in the United States District Court for the Northern District of Illinois on behalf of all persons and entities who purchased or otherwise acquired ADM common stock between... ❯❯❯

B. RILEY DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against B. Riley Financial, Inc. and Encourages Investors to Contact the Firm

NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against B. Riley Financial, Inc. (“B. Riley” or the “Company”) (NASDAQ: RILY) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired B. Riley common stock... ❯❯❯

ADAPTHEALTH ALERT: Bragar Eagel & Squire, P.C. is Investigating AdaptHealth Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against AdaptHealth Corp. (NASDAQ: AHCO) on behalf of long-term stockholders following a class action complaint that was filed against AdaptHealth on October 24, 2023 with a Class Period from August 4, 2020 to February 27, 2023; and/or (ii) traceable to the Company’s... ❯❯❯